Zurich Insurance Group (ZURN) H2 2022 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2022 earnings summary
17 Nov, 2026Executive summary
FY22 net income attributable to shareholders was $4.603bn vs $5.202bn; business operating profit (BOP) rose to $6.451bn from $5.742bn.
Reported total revenue fell to $41.750bn from $69.867bn, primarily reflecting a $12.405bn net investment loss on unit-linked investments versus a $14.388bn gain in 2021.
IFRS 17 adoption was expected to reduce opening 2022 shareholders’ equity by $8.8bn; the transition recognized $14.4bn of pre-tax contractual service margin (CSM) and a $3.9bn risk adjustment.
Financial highlights
Gross written premiums and policy fees increased to $58.848bn from $55.777bn; net earned premiums and policy fees were $44.532bn vs $43.031bn.
Net investment result on Group investments was $4.133bn vs $7.085bn, including net capital losses and impairments of $951m compared with gains of $2.038bn.
Net income after taxes was $4.923bn vs $5.425bn; basic EPS was $31.01 vs $34.99 and diluted EPS was $30.77 vs $34.66.
Operating cash flow was $5.079bn vs $3.167bn; investing cash outflow was $691m and financing cash outflow was $5.273bn.
Total assets were $377.782bn and shareholders’ equity $26.634bn at year-end, down from $435.826bn and $37.881bn, respectively, in 2021.
Outlook and guidance
IFRS 17 transition was not expected to significantly change BOP; IFRS 9 adoption was also not expected to significantly change BOP.
The estimated difference between IFRS 4 and IFRS 17 shareholders’ equity narrowed from $8.8bn at transition to $1.8bn by June 30, 2022, as market and asset-liability valuation effects shifted.
Estimated 2023 contributions to funded post-employment plans and benefits paid directly were $320m; actual contributions may differ.
Latest events from Zurich Insurance Group
- Beazley scales Specialty as targets, synergies and AI productivity advance.ZURN
Investor Day 2026 - Higher earnings and BOP, despite a sharp swing in unit-linked investment results.ZURN
H2 2018 - P&C underwriting gains lifted H1 BOP 16%, with combined ratio improving to 95.1%.ZURN
H1 2019 - COVID-19 and volatile markets cut H1 earnings, while commercial growth and capital resilience held firm.ZURN
H1 2020 - BOP rose 16%, all three-year targets were exceeded, and a CHF 20 dividend was proposed.ZURN
H2 2019 - BOP rose 60%, while P&C’s 93.9% combined ratio marked a 20-year-plus low.ZURN
H1 2021 - COVID-19 and catastrophe losses cut BOP 20%, while commercial pricing strengthened.ZURN
H2 2020 - Record 2021 profits, stronger underwriting and 212% SST support the 2022 outlook.ZURN
H2 2021 - Record BOP and 23.1% BOPAT ROE supported higher shareholder returns.ZURN
H2 2023